Information
-
Trademark
-
90603920
-
International Classifications
-
Filing Date
March 25, 2021
3 years ago
-
Transaction Date
February 01, 2024
a year ago
-
Status Date
November 21, 2022
2 years ago
-
Published for Opposition Date
February 22, 2022
2 years ago
-
Location Date
April 19, 2022
2 years ago
-
Status Code
606
-
Current Location
INTENT TO USE SECTION
Employee Name
HSU, FONG
-
Attorney Docket Number
21-0417-US
Attorney Name
Eric R. Moran
Law Office Assigned Location Code
O20
-
Owners
Mark Drawing Code
4000
Mark Identification
BYKRASO
Case File Statements
- GS0051: pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
- GS0421: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Case File Event Statements
-
11/21/2022 - 2 years ago
24 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Type: MAB6
-
11/21/2022 - 2 years ago
23 - ABANDONMENT - NO USE STATEMENT FILED
Type: ABN6
-
4/19/2022 - 2 years ago
22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
2/22/2022 - 2 years ago
21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
2/22/2022 - 2 years ago
20 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
2/2/2022 - 3 years ago
19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
1/18/2022 - 3 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
1/15/2022 - 3 years ago
17 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
1/15/2022 - 3 years ago
16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
1/15/2022 - 3 years ago
15 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
1/15/2022 - 3 years ago
14 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
12/20/2021 - 3 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
12/20/2021 - 3 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
12/20/2021 - 3 years ago
11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
11/9/2021 - 3 years ago
10 - ASSIGNED TO LIE
Type: ALIE
-
11/8/2021 - 3 years ago
9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
11/8/2021 - 3 years ago
8 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/8/2021 - 3 years ago
7 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/1/2021 - 3 years ago
6 - ASSIGNED TO EXAMINER
Type: DOCK
-
7/1/2021 - 3 years ago
5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
6/30/2021 - 3 years ago
4 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
6/30/2021 - 3 years ago
3 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
6/30/2021 - 3 years ago
2 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
3/29/2021 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP